GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » Common Stock

Nortem Biogroup (XPAR:MLBIO) Common Stock : €5.16 Mil (As of Dec. 2022)


View and export this data going back to 2023. Start your Free Trial

What is Nortem Biogroup Common Stock?

Nortem Biogroup's quarterly common stock increased from . 20 (€0.00 Mil) to Dec. 2021 (€4.19 Mil) and increased from Dec. 2021 (€4.19 Mil) to Dec. 2022 (€5.16 Mil).

Nortem Biogroup's annual common stock increased from . 20 (€0.00 Mil) to Dec. 2021 (€4.19 Mil) and increased from Dec. 2021 (€4.19 Mil) to Dec. 2022 (€5.16 Mil).

Nortem Biogroup Common Stock Historical Data

The historical data trend for Nortem Biogroup's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nortem Biogroup Common Stock Chart

Nortem Biogroup Annual Data
Trend Dec21 Dec22
Common Stock
4.19 5.16

Nortem Biogroup Semi-Annual Data
Dec21 Dec22
Common Stock 4.19 5.16

Nortem Biogroup Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Nortem Biogroup (XPAR:MLBIO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » Common Stock
Comparable Companies
Traded in Other Exchanges
N/A
Address
Calle Alexander Humboldt 12B, Polígono Industrial Salinas de Poniente, El Puerto de Santa María, Cadiz, ESP, 11500
Website
https://www.nortembiogroup.com
Nortem Chem SA is engaged in the research, development, innovation and industrialization in the field of biochemistry and biotechnology, as well as the production and sale of products based on biochemical and/or biotechnological processes. It emerged as a biotechnological company in the field of the food and chemical industry, with maximum environmental awareness, concentrating its research and product development efforts on the development of environmentally friendly alternatives from renewable sources and obtaining its own microorganisms (Aspergillus Niger and Yarrowia lipolytica) with outstanding capabilities from adaptation and selection processes, avoiding the use of genetic modification technologies.

Nortem Biogroup (XPAR:MLBIO) Headlines

No Headlines